Clinical Trial Update: Study of DA-9501 In Pediatric Subjects In The Intensive Care Unit [Phase 3]

View source ↗

Summary

Phase 3 clinical trial of DA-9501 in pediatric patients in the ICU has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Icu Sedation

Drugs mentioned

• DA-9501

Snippet

Sponsor: Pfizer | Conditions: ICU Sedation | Phase 3 | Status: COMPLETED | Results posted: 2018-12-17